Immunoglobulins, Intravenous

"Immunoglobulins, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA.

Descriptor ID	D016756
MeSH Number(s)	D12.776.124.486.485.114.619.393.536 D12.776.124.486.485.114.632 D12.776.124.790.651.114.632 D12.776.377.715.548.114.632
Concept/Terms	Immunoglobulins, Intravenous Immunoglobulins, Intravenous Intravenous IG Intravenous Antibodies IVIG Immune Globulin, Intravenous Intravenous Immune Globulin Antibodies, Intravenous Intravenous Immunoglobulins IV Immunoglobulins Immunoglobulins, IV Flebogamma DIF Flebogamma DIF Gamimune Gamimune Gamimmune Gamimune N Gamimune N Gamimmune N Gammagard Gammagard Iveegam Gammonativ Gammonativ Gamunex Gamunex Globulin-N Globulin-N Globulin N GlobulinN Intraglobin Intraglobin Intraglobin F Intraglobin F Intravenous Immunoglobulins, Human Intravenous Immunoglobulins, Human Human Intravenous Immunoglobulins Immunoglobulins, Human Intravenous Immune Globulin Intravenous (Human) Immunoglobulins, Intravenous, Human Modified Immune Globulin (Anti-Echovirus Antibody) Modified Immune Globulin (Anti-Echovirus Antibody) Privigen Privigen Venimmune Sandoglobulin Sandoglobulin Venoglobulin Venoglobulin Venoglobulin-I Venoglobulin-I Venoglobulin I VenoglobulinI Alphaglobin Alphaglobin Endobulin Endobulin

Below are MeSH descriptors whose meaning is more general than "Immunoglobulins, Intravenous".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Immunoglobulin Isotypes [D12.776.124.486.485.114.619]
Immunoglobulin G [D12.776.124.486.485.114.619.393]
Immunoglobulins, Intravenous [D12.776.124.486.485.114.619.393.536]
Immunoglobulins, Intravenous [D12.776.124.486.485.114.632]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Immunoglobulins, Intravenous [D12.776.124.790.651.114.632]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Immunoglobulins, Intravenous [D12.776.377.715.548.114.632]

Below are MeSH descriptors whose meaning is related to "Immunoglobulins, Intravenous".

Below are MeSH descriptors whose meaning is more specific than "Immunoglobulins, Intravenous".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Immunoglobulins, Intravenous" by people in this website by year, and whether "Immunoglobulins, Intravenous" was a major or minor topic of these publications.

Bar chart showing 38 publications over 22 distinct years, with a maximum of 3 publications in 1993 and 2010 and 2016 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	3	0	3
1994	1	0	1
1995	1	0	1
1997	1	0	1
1998	2	0	2
2000	1	1	2
2002	0	1	1
2003	1	1	2
2004	2	0	2
2006	0	2	2
2007	0	1	1
2010	2	1	3
2011	0	1	1
2012	0	1	1
2013	0	2	2
2014	1	0	1
2016	3	0	3
2017	1	2	3
2018	0	1	1
2019	1	1	2
2020	1	0	1
2021	2	0	2

Below are the most recent publications written about "Immunoglobulins, Intravenous" by people in Profiles.

Willenbrink TJ, Robinson IS, Connett JS, Wine Lee L. Psoriasiform dermatitis following intravenous immunoglobulin therapy: A case series. Pediatr Dermatol. 2021 Nov; 38(6):1529-1531.

View in: PubMed
Son MBF, Murray N, Friedman K, Young CC, Newhams MM, Feldstein LR, Loftis LL, Tarquinio KM, Singh AR, Heidemann SM, Soma VL, Riggs BJ, Fitzgerald JC, Kong M, Doymaz S, Giuliano JS, Keenaghan MA, Hume JR, Hobbs CV, Schuster JE, Clouser KN, Hall MW, Smith LS, Horwitz SM, Schwartz SP, Irby K, Bradford TT, Maddux AB, Babbitt CJ, Rowan CM, McLaughlin GE, Yager PH, Maamari M, Mack EH, Carroll CL, Montgomery VL, Halasa NB, Cvijanovich NZ, Coates BM, Rose CE, Newburger JW, Patel MM, Randolph AG. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes. N Engl J Med. 2021 07 01; 385(1):23-34.

View in: PubMed
Johnson SC, Williams DC, Brinton D, Chew M, Simpson A, Andrews AL. A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.

View in: PubMed
Gnann JW, Agrawal A, Hart J, Buitrago M, Carson P, Hanfelt-Goade D, Tyler K, Spotkov J, Freifeld A, Moore T, Reyno J, Masur H, Jester P, Dale I, Li Y, Aban I, Lakeman FD, Whitley RJ. Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease. Emerg Infect Dis. 2019 11; 25(11):2064-2073.

View in: PubMed
Clifford KM, Hobson-Webb LD, Benatar M, Burns TM, Barnett C, Silvestri NJ, Howard JF, Visser A, Crum BA, Nowak R, Beekman R, Kumar A, Ruzhansky K, Chen IA, Pulley MT, Laboy SM, Fellman MA, Howard DB, Kolb NA, Greene SM, Pasnoor M, Dimachkie MM, Barohn RJ, Hehir MK. Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis. Muscle Nerve. 2019 04; 59(4):404-410.

View in: PubMed
Bhatia S, Schmitt SE. Treating Immune-Related Epilepsy. Curr Neurol Neurosci Rep. 2018 02 14; 18(3):10.

View in: PubMed
Fleming JN, Taber DJ, Weimert NA, Nadig S, McGillicuddy JW, Bratton CF, Baliga PK, Chavin KD. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).

View in: PubMed
Valdebran M, Amber KT. Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers. JAMA Dermatol. 2017 11 01; 153(11):1189-1190.

View in: PubMed
Kizilbash S, Claes D, Ashoor I, Chen A, Jandeska S, Matar RB, Misurac J, Sherbotie J, Twombley K, Verghese P. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study. Pediatr Transplant. 2017 May; 21(3).

View in: PubMed
Farhood Z, Ong AA, Discolo CM. PANDAS: A systematic review of treatment options. Int J Pediatr Otorhinolaryngol. 2016 Oct; 89:149-53.

View in: PubMed

People

Explore

Similar Concepts

Top Journals